I think you should all stop speculating and/or guessing and read Canon Inc.'s latest annual report & accounts:
http://www.canon.com/ir/annual/2011/report2011.pdfOf $17.4 billion in Total Operating Expenses in FY 2011 a total of $4bn was spent on R&D (actually $3,946 million) across all 3 major divisions: Office, Consumer (DSLR incl.) and Industrial, but if you read p.48 on R&D, most was spent on non-Consumer stuff.
Total 2011 R&D was 8.7% of Net SalesLast year Canon spent > $1 billion on 'Advertising' alone. Further 'Selling, Marketing and Administrative' expenses totaled another $12 billion. Of the 3 major components of cost identified by Canon:- Labour, R&D, and Marketing/Advertising,
Research & Development is less than one quarter.
R&D is dwarfed by Selling/Marketing/Advertising budget. Same goes for all major multinational corporations (e.g. 'Big-Pharma' spend one-tenth on R&D as they do on Marketing & Advertising).
The only mention on Consumer Business Unit R&D was the
reduced need to make prototypes and the declining costs.
On the other hand, some
56% of Canon's US$4.8 billion 2011 Op profit came from Consumer (includes DSLR) business, yet that strategic business unit accounts for just
36% of sales. So selling Cameras is more profitable than selling other products in their other two divisions.
R&D has fallen in recent years e.g. in 2009 was 9.5% of Net Sales, the following year 2010 it fell to 8.5%.
Finally, read the key pages in the annual report, and you will see a clear trend. Fewer prototypes in Consumer Business, more R&D directed at Office & Industrial, boost the number of Marketing Subsidiaries (see page 101 - Marketing totally dominates, especially R&D), more products using overlapping technology (e.g. same sensor or same AF, same battery etc.), plus most of the sales growth in
Non-Japan Asia and Emerging Markets (ie.
not the Americas or Europe), so basic thrust is to sell more of existing technology to boost revenues.
Look at pages 51-52 where they discuss the apparent demand for higher MP in DSLR but instead emphasize the imperative to boost sales support in developing markets as the main priority
etc ad nauseam ....